​

Funding Round

Series A - Blue Note Therapeutics

Series A - Blue Note Therapeutics

Investment Firm

Overview

Blue Note Therapeutics is a prescription digital therapeutics company that merges deep scientific and clinical expertise.

Announced Date

Sep 09, 2021

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

3

Investor Name
Participant InvestorGreen D Ventures
Participant InvestorMemorial Sloan - Kettering Cancer Center
Participant InvestorJazz Venture Partners

Round Details and Background

Blue Note Therapeutics raised $5200000 on 2021-09-09 in Series A

Blue Note Therapeutics is a prescription digital therapeutics company that merges deep scientific and clinical expertise.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 12, 2021
Venture Round - Blue Note Therapeutics
-15.5M
Mar 03, 2021
Series A - Blue Note Therapeutics
2-26.3M
Sep 09, 2021
Series A - Blue Note Therapeutics
5-5.2M

Recent Activity

There is no recent news or activity for this profile.